| 2ydx |
Crystal structure of human S-adenosylmethionine synthetase 2, beta subunit |
3 |
3 |
X-RAY DIFFRACTION |
| 2ydy |
Crystal structure of human S-adenosylmethionine synthetase 2, beta subunit in Orthorhombic crystal form |
1 |
1 |
X-RAY DIFFRACTION |
| 2ydz |
X-ray structure of the cyan fluorescent protein SCFP3A (K206A mutant) |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye0 |
X-ray structure of the cyan fluorescent protein mTurquoise (K206A mutant) |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye1 |
X-ray structure of the cyan fluorescent proteinmTurquoise-GL (K206A mutant) |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye2 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye3 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye4 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye5 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye6 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye7 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye8 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2ye9 |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yea |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yeb |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yec |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yed |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yee |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yef |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yeg |
HSP90 inhibitors and drugs from fragment and virtual screening |
2 |
2 |
X-RAY DIFFRACTION |
| 2yeh |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yei |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yej |
HSP90 inhibitors and drugs from fragment and virtual screening |
1 |
1 |
X-RAY DIFFRACTION |
| 2yek |
Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GSK525762 (IBET) |
2 |
2 |
X-RAY DIFFRACTION |
| 2yel |
Crystal Structure of the First Bromodomain of Human Brd4 with the inhibitor GW841819X |
1 |
1 |
X-RAY DIFFRACTION |
| 2yem |
Crystal Structure of the Second Bromodomain of Human Brd4 with the inhibitor GW841819X |
2 |
2 |
X-RAY DIFFRACTION |
| 2yen |
Solution structure of the skeletal muscle and neuronal voltage gated sodium channel antagonist mu-conotoxin CnIIIC |
20 |
20 |
SOLUTION NMR |
| 2yeo |
A39L mutation of scorpion toxin lqh-alpha-it |
1 |
1 |
X-RAY DIFFRACTION |
| 2yep |
STRUCTURE OF AN N-TERMINAL NUCLEOPHILE (NTN) HYDROLASE, OAT2, IN COMPLEX WITH GLUTAMATE |
4 |
4 |
X-RAY DIFFRACTION |
| 2yeq |
Structure of PhoD |
3 |
3 |
X-RAY DIFFRACTION |
| 2yer |
Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors |
1 |
1 |
X-RAY DIFFRACTION |
| 2yes |
Crystal Structure of Rv0371C complex with Manganese from Mycobacterium Tuberculosis H37Rv |
2 |
2 |
X-RAY DIFFRACTION |
| 2yet |
Thermoascus GH61 isozyme A |
2 |
2 |
X-RAY DIFFRACTION |
| 2yeu |
Structural and functional insights of DR2231 protein, the MazG-like nucleoside triphosphate pyrophosphohydrolase from Deinococcus radiodurans, complex with Gd |
3 |
3 |
X-RAY DIFFRACTION |
| 2yev |
Structure of caa3-type cytochrome oxidase |
2 |
2 |
X-RAY DIFFRACTION |
| 2yew |
Modeling Barmah Forest virus structural proteins |
1 |
5 |
ELECTRON MICROSCOPY |
| 2yex |
Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors |
1 |
1 |
X-RAY DIFFRACTION |
| 2yey |
Crystal structure of the allosteric-defective chaperonin GroEL E434K mutant |
1 |
1 |
X-RAY DIFFRACTION |
| 2yez |
COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE |
1 |
1 |
X-RAY DIFFRACTION |
| 2yf0 |
Human Myotubularin related protein 6 (MTMR6) |
1 |
1 |
X-RAY DIFFRACTION |
| 2yf2 |
Crystal structure of the oligomerisation domain of C4b-binding protein from Gallus gallus |
1 |
1 |
X-RAY DIFFRACTION |
| 2yf3 |
Crystal structure of DR2231, the MazG-like protein from Deinococcus radiodurans, complex with manganese |
3 |
3 |
X-RAY DIFFRACTION |
| 2yf4 |
Crystal structure of DR2231, the MazG-like protein from Deinococcus radiodurans, Apo structure |
3 |
3 |
X-RAY DIFFRACTION |
| 2yf9 |
STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, NATIVE FORM |
1 |
1 |
X-RAY DIFFRACTION |
| 2yfa |
X-ray structure of McpS ligand binding domain in complex with malate |
1 |
1 |
X-RAY DIFFRACTION |
| 2yfb |
X-ray structure of McpS ligand binding domain in complex with succinate |
1 |
1 |
X-RAY DIFFRACTION |
| 2yfc |
STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, COMPLEXED WITH Mn and dUMP |
2 |
2 |
X-RAY DIFFRACTION |
| 2yfd |
STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, COMPLEXED WITH Mg and dUMP |
2 |
2 |
X-RAY DIFFRACTION |
| 2yfe |
Ligand binding domain of human PPAR gamma in complex with amorfrutin 1 |
2 |
2 |
X-RAY DIFFRACTION |
| 2yfh |
Structure of a Chimeric Glutamate Dehydrogenase |
1 |
1 |
X-RAY DIFFRACTION |